Free Trial

Kinaxis (TSE:KXS) Price Target Cut to C$200.00 by Analysts at TD Securities

Kinaxis logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • TD Securities cut its price target on Kinaxis to C$200 (from C$229) but kept a "buy" rating, which implies roughly a 45.85% upside from the current share price.
  • Multiple brokers have trimmed targets toward ~C$200 (BMO at C$180), leaving a consensus of "Moderate Buy" with an average target of C$208.67 (six Buys, one Hold).
  • Kinaxis shares trade near C$137.13 with a C$3.79B market cap and a high P/E (~114); the company reported C$0.93 EPS on C$189.95M revenue last quarter, indicating growth expectations despite recent price weakness.
  • MarketBeat previews top five stocks to own in May.

Kinaxis (TSE:KXS - Get Free Report) had its target price dropped by TD Securities from C$229.00 to C$200.00 in a research report issued on Friday,BayStreet.CA reports. The brokerage currently has a "buy" rating on the stock. TD Securities' target price suggests a potential upside of 45.85% from the stock's current price.

Several other research firms have also recently weighed in on KXS. Canaccord Genuity Group lowered their price objective on Kinaxis from C$225.00 to C$200.00 in a research report on Friday. Canadian Imperial Bank of Commerce raised shares of Kinaxis from a "hold" rating to an "outperform" rating and boosted their price objective for the company from C$201.00 to C$203.00 in a report on Monday, December 15th. Royal Bank Of Canada lowered their target price on shares of Kinaxis from C$235.00 to C$200.00 and set an "outperform" rating on the stock in a report on Monday, January 26th. Scotiabank lowered their price objective on Kinaxis from C$240.00 to C$200.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 4th. Finally, BMO Capital Markets decreased their price target on Kinaxis from C$225.00 to C$180.00 in a research report on Monday. Six investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of C$208.67.

Check Out Our Latest Research Report on KXS

Kinaxis Stock Performance

Shares of TSE:KXS traded up C$2.49 on Friday, hitting C$137.13. The company had a trading volume of 115,354 shares, compared to its average volume of 148,950. The stock has a 50 day moving average price of C$145.09 and a 200 day moving average price of C$168.04. The company has a current ratio of 2.24, a quick ratio of 2.29 and a debt-to-equity ratio of 10.96. The stock has a market cap of C$3.79 billion, a price-to-earnings ratio of 114.28, a P/E/G ratio of 3.60 and a beta of 0.76. Kinaxis has a 1-year low of C$117.22 and a 1-year high of C$212.45.

Kinaxis (TSE:KXS - Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported C$0.93 EPS for the quarter. Kinaxis had a net margin of 6.59% and a return on equity of 8.18%. The business had revenue of C$189.95 million for the quarter. Analysts expect that Kinaxis will post 4.2526231 EPS for the current year.

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation. Kinaxis's S&OP solution capabilities include supply and demand planning, capacity and inventory planning, and inventory management. The firm has operations in North America, Europe, and Asia-Pacific regions.

Further Reading

Analyst Recommendations for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines